Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial
International Journal of Methods in Psychiatric Research · 2025
DOI: 10.1002/mpr.70014 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Methods in Psychiatric Research, 2025. Verfasst von Camille André und 15 weiteren Autor:innen. Beteiligte Einrichtung: Groupe de Recherche sur l'Alcool & les Pharmacodépendances, INSERM UMR 1247, Université de Picardie Jules Verne, Amiens, France. Hauptthemen laut MEDLINE: Binge Drinking, Glycerophospholipids, Students, Mobile Applications. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National Du Cancer, Institut pour la Recherche en Santé Publique.
Abstract (Originalsprache)
Objective
The purpose of this paper is to describe a study protocol of a clinical trial exploring the effectiveness of the new mobile application MyDéfi proposing personalized feedback, on both alcohol consumption and quality of life, as well as the blood alcohol exposure biomarker phosphatidylethanol, in university students displaying binge drinking behavior.
Methods
This prospective national multicentric randomized, two‐arm (1:1), double‐blind controlled trial will recruit 628 students (aged 18–25 years) with binge drinking behavior. Participants will be randomized in the “intervention” group (personalized feedback) or the “control” group (generic feedback) and will undergo four monthly visits. Monthly dried blood spot sample for measuring phosphatidylethanol concentration and online questionnaires will be collected. Our primary objective is to assess the reduction weekly standard drinks, through self‐report gathered via MyDéfi. Secondary objectives will evaluate the application's impact on the dosage of phosphatidylethanol blood concentration and on quality of life”.
Results
Recruitment started in March 2024 and will end in March 2026.
Conclusion
This study aims to determine the effectiveness of two versions of the same mobile application (generic vs. personalized feedback) on alcohol consumption in students displaying binge drinking behavior. The effectiveness of the application will be measured, with a secondary objective of quantifying phosphatidylethanol. Our study will open new perspectives on the use of digital interventions for students who do not actively seek treatment. Trial Registration Trial registration number (NCT06084832), the date of registration (10th October 2023) and when this was done (16th October 2023). https://clinicaltrials.gov/study/NCT06084832
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Groupe de Recherche sur l'Alcool & les Pharmacodépendances, INSERM UMR 1247, Université de Picardie Jules Verne, Amiens, France.
- Department of Statistics, Amiens Hospital University, Amiens, France.
- Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
- University of Paul Valéry Montpellier 3, Montpellier, France.
- Laboratory SCALab, UMR CNRS 9193, University of Lille, Villeneuve d'Ascq, France.
- Cognition Health Society Laboratory (C2S - EA 6291), University of Reims Champagne Ardenne, Reims, France.
ORCID-Profile: Camille André, Pierre Sauton, Méléna Dreinaza, Momar Diouf, Sandra Bodeau, Margaret Martinetti, Raphaël Trouillet, Clara de Groote, Jean-Louis Nandrino, Farid Benzerouk, Fabien Gierski, Pascal Perney, Laure Grellet, Judith André, Mickael Naassila
Förderung
- Institut National Du Cancer
- Institut pour la Recherche en Santé Publique
Zitieren
APA
André, C., Sauton, P., Dreinaza, M., Diouf, M., Bodeau, S., Martinetti, M., Trouillet, R., de Groote, C., Nandrino, J. L., Alexandre, A., Benzerouk, F., Gierski, F., Perney, P., Grellet, L., André, J., & Naassila, M. (2025). Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial. International Journal of Methods in Psychiatric Research. https://doi.org/10.1002/mpr.70014
Vancouver
André C, Sauton P, Dreinaza M, Diouf M, Bodeau S, Martinetti M, et al. Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial. International Journal of Methods in Psychiatric Research. 2025. doi:10.1002/mpr.70014
BibTeX
@article{Andr2025,
author = {André, Camille and Sauton, Pierre and Dreinaza, Méléna and Diouf, Momar and Bodeau, Sandra and Martinetti, Margaret and Trouillet, Raphaël and de Groote, Clara and Nandrino, Jean-Louis and Alexandre, Adèle and Benzerouk, Farid and Gierski, Fabien and Perney, Pascal and Grellet, Laure and André, Judith and Naassila, Mickael},
title = {Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker—The SMARTBINGE Trial},
journal = {International Journal of Methods in Psychiatric Research},
year = {2025},
doi = {10.1002/mpr.70014}
}
EUVIMED